31 related articles for article (PubMed ID: 25644425)
1. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.
Bhatia P; Deniwar A; Friedlander P; Aslam R; Kandil E
Anticancer Res; 2015 Mar; 35(3):1237-41. PubMed ID: 25750270
[TBL] [Abstract][Full Text] [Related]
3. Subclassification of follicular neoplasms recommended by the Japan thyroid association reporting system of thyroid cytology.
Kakudo K; Kameyama K; Hirokawa M; Katoh R; Nakamura H
Int J Endocrinol; 2015; 2015():938305. PubMed ID: 25722720
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cytopathology reporting by the bethesda system: a two-year prospective study in an academic institution.
Mehra P; Verma AK
Patholog Res Int; 2015; 2015():240505. PubMed ID: 25688327
[TBL] [Abstract][Full Text] [Related]
5. Reliability of Thyroid FNAC as a Single Diagnostic Modality: A Systematic Review.
Poduval J; Bhat V; Naik P
Indian J Otolaryngol Head Neck Surg; 2019 Oct; 71(Suppl 1):167-171. PubMed ID: 31741954
[TBL] [Abstract][Full Text] [Related]
6. The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.
Koh J; Moon HJ; Kim EK; Kwak JY; Yoon JH
Endocrine; 2016 Aug; 53(2):489-96. PubMed ID: 26758996
[TBL] [Abstract][Full Text] [Related]
7. Thyroid cytopathology: updates and molecular testing.
Vance J; Gilani SM
Pathologica; 2019 Jun; 111(2):51-57. PubMed ID: 31388195
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
9. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
Onder S; Firat P; Ates D
Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
[TBL] [Abstract][Full Text] [Related]
10. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Bethesda reporting category, 'suspicious for papillary thyroid carcinoma', pitfalls and clues to optimize the use of this category.
Mahajan A; Lin X; Nayar R
Cytopathology; 2013 Apr; 24(2):85-91. PubMed ID: 22356185
[TBL] [Abstract][Full Text] [Related]
12. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
14. Reducing indeterminate thyroid FNAs.
Renshaw AA; Gould EW
Cancer Cytopathol; 2015 Apr; 123(4):237-43. PubMed ID: 25644425
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]